Symbol: |
BTBD9
|
Description: |
BTB (POZ) domain containing 9 [Source:HGNC Symbol;Acc:21228]
|
Location: |
Chr6:38136227-38607924[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:120
Gene |
Compound |
Gen_sig |
Exp_pattern |
BTBD9 |
Thiothixene |
0.049 |
Down |
BTBD9 |
NSC 11850 |
0.013 |
Down |
BTBD9 |
Ethanesulfonic acid, compd. with 5-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]-o-toluenesulfonyl fluoride (1:1) |
0.043 |
Up |
BTBD9 |
VERNOLIDE |
0.037 |
Down |
BTBD9 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.021 |
Up |
BTBD9 |
NSC 142506 |
0.005 |
Down |
BTBD9 |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.023 |
Down |
BTBD9 |
1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- |
0.044 |
Down |
BTBD9 |
1-Piperidineethanol, .alpha.-[p-(p-chlorostyryl)phenyl]- |
0.041 |
Down |
BTBD9 |
NANAOMYCIN |
0.044 |
Down |
BTBD9 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.01 |
Up |
BTBD9 |
Cycloalkannin |
0.014 |
Down |
BTBD9 |
MELAMPODIN B ACETATE |
0.033 |
Down |
BTBD9 |
Chlorazin |
0.005 |
Up |
BTBD9 |
Amquinate |
0.024 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:163
Total:11 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:48
Gene |
Gen_transcript |
miRNA |
miR_location |
BTBD9 |
ENST00000373384 |
hsa-mir-649 |
Chr22:21388480-21388501[-] |
BTBD9 |
ENST00000373384 |
hsa-mir-769-5p |
Chr19:46522219-46522240[+] |
BTBD9 |
ENST00000373384 |
hsa-mir-875-3p |
Chr8:100549025-100549045[-] |
|